EKF Diagnostics (LON:EKF) Reaches New 1-Year Low – Here’s Why

Shares of EKF Diagnostics Holdings plc (LON:EKFGet Free Report) hit a new 52-week low on Monday . The company traded as low as GBX 20 ($0.26) and last traded at GBX 19.70 ($0.26), with a volume of 244628 shares traded. The stock had previously closed at GBX 20.31 ($0.26).

EKF Diagnostics Stock Down 5.4 %

The company has a debt-to-equity ratio of 0.34, a current ratio of 4.60 and a quick ratio of 1.77. The stock has a market capitalization of £86.16 million, a PE ratio of 18.04 and a beta of 0.57. The company has a 50 day moving average price of GBX 24.65 and a 200-day moving average price of GBX 26.41.

EKF Diagnostics Company Profile

(Get Free Report)

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.

Read More

Receive News & Ratings for EKF Diagnostics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EKF Diagnostics and related companies with MarketBeat.com's FREE daily email newsletter.